Both in Pharmaceuticals
Immunome vs Palvella Therapeutics
Over the past year IMNM returned +14.0% and PVLA returned +86.4%; their daily moves had a correlation of 0.31.
IMNM +14.0% PVLA +86.4%Growth of $1, one year, split-adjusted
| Metric | IMNM | PVLA |
|---|---|---|
| Price | $18.21 | $146.15 |
| Market cap | $2.15B | $2.11B |
| Today | −0.44% | −3.58% |
| 1 month | −12.8% | +10.1% |
| 6 months | −19.9% | +15.2% |
| Year to date | −15.2% | +39.6% |
| 1 year | +15.5% | +94.4% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $520.0M | $250.6M |
| Dividend yield | — | — |
| Volatility (60d) | 55.6% | 47.0% |
| Short % of float | 17.1% | 21.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).